68 results
8-K
EX-99.1
ARCT
Arcturus Therapeutics Holdings Inc
28 Feb 22
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
4:15pm
Current portion of long-term debt
Deferred revenue
Total current liabilities
Deferred revenue, net of current portion
Long-term debt, net of current … portion
Operating lease liability, net of current portion
Other long-term liabilities
Total liabilities
Stockholders’ equity
Common stock: $0.001 par
8-K
EX-99.1
vwa56m7m5qro uv9c
9 Aug 22
Arcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline Progress
12:00am
DEFR14A
coo48
12 May 22
Revised proxy
5:00pm
8-K
EX-99.1
gu9b8c
15 Aug 19
Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update
8:09am
8-K
EX-99.1
bcmcbxtm6bgupgaeplrm
9 Nov 22
Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress
4:06pm
8-K
EX-99.1
2j9lbxblsk9unkk57
10 May 21
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
4:21pm
8-K
EX-99.1
u5ikrk9
8 Nov 21
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress
4:18pm
8-K
EX-99.1
n17mc986nygo2bpw4
9 May 23
Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress
4:11pm